Drawing for Serial No. 90027024

USPTO serial 90027024

Serial No. 90027024

Reviewed by CopyMark Law Group

Reg. 6775548Status 700Registered
Filing date
Status date
Registration date
Jun 28, 2022
Examiner
BEVERLY, JOSETTE MICHELLE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 90027024?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Darren B. Cohen

Darren B. Cohen REED SMITH LLP599 LEXINGTON AVENUENEW YORK, NY 10022UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business advisory, development, and strategic planning services provided to companies for business purposes in the life sciences industries; Business consultation services in the field of GxP (Good Practice) compliance; Business consulting services on processes and workflows related to content creation, localization and publishing strategy including Translation Memory and Terminology Management, Quality Management, Life Sciences Regulatory Compliance and Risk Management; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Regulatory submission management, namely, assisting others in preparing and filing applications for new medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology with governmental regulatory bodies around the world; Regulatory submission management, namely, providing simultaneous multiple country submissions of applications for the registration and approval of medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology; providing information online regarding regulatory submission management; Business management consulting, strategic planning and business advisory services provided to medical, medical technology, biopharmaceutical, and biotechnology companies, and government agencies, educational and research institutions, law firms, and investment firms in the fields of biologics, pharmaceuticals and medical devices; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for drug and medical device approval; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs and medical devices with governmental regulatory bodies; Business consulting services in the field of biologics, pharmaceuticals, prescription drugs and medical devices; Business consulting and management for companies in the life sciences fields pertaining to business operations including standard operating procedures, audits and assessments; Business consulting and for companies in the life sciences fields related to supply chain management, including, internet of medical things (IoMT), connected service and quality management, product lifecycle management, product master management, and enterprise resource planning; Providing quality and IT staffing services for companies in the life sciences fields and employment consultation pertaining to staffing augmentation services and onsite and remote on-demand compliance staff augmentation; Business consulting and management for companies in the life sciences fields pertaining to business operations including information and data compiling and analyzing relating to business management; consulting services in the field of medical device product approval for commercial purposes; Business consulting and management for companies in the life sciences fields for use in the following applications: validation and qualification; including, computer software assurance, manufacturing system validation, laboratory equipment and instrumentation, process validation and cleaning validation, laboratory information management systems (LIMS), facilities and utilities, and manufacturing systems; Business consulting and management for companies in the life sciences fields for use in the following applications: compliance strategy: including laboratory validation, assessments, strategy and remediation planning, performing remediation activities, and providing advisory services to assist GxP labs in meeting commercial and regulatory requirements; Business consulting and management for companies in the life sciences fields for use in the following applications: digital transformation strategy, including: support on demand services, development on demand services; Business consulting and management for companies in the life sciences fields for use in the following applications: management; including life sciences and program management, GxP cloud services, and organizational change managementACTIVENov 5, 2013
041Providing educational programs in the life science fields using on-line activities, non-downloadable webinars and blogs, workshops, and printable materials distributed therewith featuring Regulatory issues and developments, GxP (Good Practice) Compliance, Risk Management, Design Control, QMS (Quality Management Solutions), CSV (Computer System Validation), SOP (Standard Operating Procedures), Data Integrity, UDI (Unique Device Identification), Regulatory readiness, and other related practice areas in the life sciences fieldsACTIVENov 5, 2013
042Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; biotechnology research consulting services; pharmaceutical research and product development for use in manufacturing; information technology consultation services; computer aided design services; Consulting services for others in the field of designing pre-clinical and clinical studies and trials for others; product research and development for others in the fields of biologics, pharmaceuticals, prescription drugs and medical devices; quality management services, namely, quality evaluation and analysis, quality assurance and quality control in the field of biologics, pharmaceuticals, prescription drugs and medical devices; scientific consulting and research services relating to the field of pharmaceuticals, medical devices, and life sciences, namely, biology, and medicine; design and development and technical verification consulting services in the fields of biotechnology and pharmaceutical research, and scientific and technological services, namely, scientific research, analysis, testing, and related scientific studies in the field of chemistry and molecular biology, namely, biologics and protein detection, characterization, analysis and testing; Computer consulting services in the field of cloud computing in the field of life science; Technical and scientific research consulting and computer project management for companies in the life sciences fields pertaining to cloud-based data migration; Technical and scientific consulting and management for companies in the life sciences fields pertaining to technical verification and validation laboratory equipment and instrumentation; Technical and scientific consulting and management for companies in the life sciences fields pertaining to digital compression of computer data; Technical and scientific consulting and management for companies in the life sciences fields pertaining to GxP (Good Practice) cloud seeding services; Technical and scientific consulting and management for companies in the life sciences fields for use in the following applications: regulation support; including standard operating procedures, customized compliance training programs, clinical compliance as service (CaaS), medical device cybersecurity, medical device compliance, data integrity, serialization/track and trace, global unique device identification, good clinical practice (GCP) compliance and quality assurance, risk-based monitoring, auditing as a service (AaaS), risk management, remediation planning and execution, emerging companies compliance roadmapping, EU MDR and IVDR compliance, and audits and assessments; Technical and management for companies in the life sciences fields for use in the following applications: supply chain management; including, internet of medical things (IoMT), connected service and quality management, product lifecycle management, product master data management, and enterprise resource planning; Technical and scientific consulting and management for companies in the life sciences fields for use in the following applications: compliance strategy: including laboratory validation, assessments, strategy and remediation planning, performing remediation activities, and providing advisory services to assist GxP labs in meeting commercial and regulatory requirements; Technical and scientific consulting and management for companies in the life sciences fields for use in the following applications: management; including life sciences and program management, GxP cloud services, and organizational change management (OCM)ACTIVENov 5, 2013
045Regulatory compliance consulting services in the life sciences fields, namely, reviewing standards and practices to assist clients with compliance with governmental laws, regulations and rules pertaining to medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology; providing technical regulatory affair consulting services directed to medical, medical technology, biopharmaceutical, and biotechnology companies in order to assure compliance with food and drug administration's laws and regulations; provision of information online pertaining to regulatory compliance in the fields of medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology; and regulatory compliance consulting in the fields of biologics, pharmaceuticals, prescription drugs and medical devicesACTIVENov 5, 2013

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 28, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 28, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 27, 2022SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 26, 2022CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 15, 2022SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 14, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 27, 2022IUAFUSE AMENDMENT FILED—
Mar 27, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 28, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 3, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 3, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 14, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 29, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 8, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 7, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 7, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 5, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 5, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 5, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 28, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 27, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 27, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 15, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 15, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 15, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2020DOCKASSIGNED TO EXAMINER—
Jul 28, 2020MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 27, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 2, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance